Effectiveness of a Care Model for Sarcopenic Obesity in Older Adults on Fat Mass, Muscle Mass, Muscle Strength, and Physical Performance

April 8, 2026 updated by: Nuchthida Samaisong, Srinakharinwirot University
Older adults

Study Overview

Status

Enrolling by invitation

Conditions

Intervention / Treatment

Detailed Description

Sarcopenic obesity rehabilitation and health behaviors modification will delivered to older adults with sarcopenic obesity

Study Type

Interventional

Enrollment (Estimated)

66

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Thailand
    • Changwat Nakhon Nayok
      • Nakhon Nayok, Changwat Nakhon Nayok, Thailand, 26000
        • Faculty of Nursing, Srinakharinwirot University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

- Diagnosis with sarcopenic obesity

  • obesity followed by WHO criteria for asian (BMI >25 kg/m2)
  • sarcopenia followed by Asian Working Group of Sarcopenia (AWGS)

Exclusion Criteria:

  • Heart disease
  • renal disease
  • cancer with active treatment
  • other disease that may effect muscle mass

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Sequential Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Control group
Subjects received usual care, if they have any health problems they will be meet the doctors
Behavioral: sarcopenic obesity modification programe
Subjects received health intervention for improve sarcopenic obesity including diet and exercise

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Body fat
Time Frame: 16 weeks
Body fat percentage of each subject (%)
16 weeks
Muscle mass
Time Frame: 16 weeks
Skeletal muscle index (SMI) (kilogram/m^2)
16 weeks
Physical performance
Time Frame: 16 weeks
5 time sit-stand (seconds)
16 weeks
Physical performance2
Time Frame: 16 weeks
6 meters walk (seconds)
16 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Srinakharinwirot University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 4, 2025

Primary Completion (Estimated)

April 6, 2026

Study Completion (Estimated)

April 6, 2026

Study Registration Dates

First Submitted

March 31, 2026

First Submitted That Met QC Criteria

April 8, 2026

First Posted (Actual)

April 13, 2026

Study Record Updates

Last Update Posted (Actual)

April 13, 2026

Last Update Submitted That Met QC Criteria

April 8, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • Sarcopenic obesity

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sarcopenic Obesity

Clinical Trials on sarcopenic obesity modification programe

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hong Kong

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe